Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Zerodha | Nippon India |
| NAV | ₹10.2682 | ₹29.1708 |
| NAV date | 19 Nov 2026 | 19 Nov 2026 |
| History | 1.1 years | 5.4 years |
| Expense ratio | 0.1% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +11.53% | +10.76% |
| 3 months | +6.15% | +7.79% |
| 6 months | +9.02% | +14.37% |
| YTD | −1.17% | +25.34% |
| 1 year | −0.86% | +25.28% |
| 3 years (CAGR) | — | +21.97% |
| 5 years (CAGR) | — | +16.60% |
| 10 years (CAGR) | — | — |
| Since launch | −0.03% | +14.02% |
Risk
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | — | 15.0% |
| Downside volatility | — | 9.0% |
| Sharpe | — | 1.03 |
| Sortino | — | 1.71 |
| Calmar | — | 1.33 |
| Return / risk | — | 1.47 |
| Deepest fall | −15.03% | −20.98% |
| Days to recover | — | 136 |
| Below its high | −1.92% | −1.80% |
Against benchmark
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | — | −0.00% |
| Beta | — | 1.00 |
| R² | — | 100.0% |
| Up capture | — | 100.0% |
| Down capture | — | 100.0% |
| Tracking error | — | 0.0% |
| Information ratio | — | — |
| Treynor | — | 0.14 |
Consistency
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | −0.62% | +65.21% |
| Middle 1-year | −5.33% | +13.45% |
| Worst 1-year | −11.66% | −15.30% |
| 1-year periods with a loss | 100.0% | 25.8% |
| Middle 3-year | — | +20.51% |
| Positive months | — | 61.1% |
| Best day | +3.78% | +3.64% |
| Worst day | −3.26% | −4.03% |
| Worst 5% day | −1.53% | −1.62% |
| Positive days | 49.8% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Zerodha CASE Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | — | +20.60% |
| 5-year value | — | ₹10,11,201 |
| 3-year XIRR | — | +19.58% |
| 1-year XIRR | +9.41% | +34.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.